BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,244,411 | -8.6% | 176,763 | +8.3% | 0.00% | -50.0% |
| Q1 2023 | $1,360,779 | -41.8% | 163,163 | -19.9% | 0.00% | -33.3% |
| Q4 2022 | $2,337,718 | +48.3% | 203,634 | +62.8% | 0.00% | +50.0% |
| Q3 2022 | $1,576,000 | -47.7% | 125,068 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $3,014,000 | +5.9% | 284,851 | +62.8% | 0.00% | +33.3% |
| Q1 2022 | $2,846,000 | -32.8% | 175,017 | -42.8% | 0.00% | -25.0% |
| Q4 2021 | $4,235,000 | +19.6% | 305,751 | +24.1% | 0.00% | 0.0% |
| Q3 2021 | $3,541,000 | -35.4% | 246,446 | -28.9% | 0.00% | -33.3% |
| Q2 2021 | $5,483,000 | +2816.5% | 346,833 | +598.3% | 0.01% | – |
| Q2 2019 | $188,000 | – | 49,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |